Down syndrome maternal serum screening in patients with renal disease

被引：7
|
作者：
Benachi, Alexandra [2 ]
Dreux, Sophie [1 ]
Kaddioui-Maalej, Sahar [2 ]
Czerkiewicz, Isabelle [1 ]
Fakhouri, Fadi [3 ]
Thervet, Eric [4 ]
Muller, Francoise [1 ]
机构：
[1] Univ Paris Ile France Ouest, Dept Biochem, Hop Robert Debre, Assistance Publ Hop Paris, F-75019 Paris, France
[2] Univ Paris 05, Dept Obstet & Gynecol, Hop Necker Enfants Malad, Assistance Publ Hop Paris, Paris, France
[3] Assistance Publ Hop Paris, Dept Nephrol, Hop Necker Enfants Malad, Paris, France
[4] Assistance Publ Hop Paris, Dept Renal Transplantat, Hop Necker Enfants Malad, Paris, France
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2010年 / 203卷 / 01期
关键词：
pregnancy; prenatal diagnosis; renal failure; trisomy; 21; NUCHAL TRANSLUCENCY; GONADOTROPIN; PREGNANCY; CREATININE; MARKER;
D O I：
10.1016/j.ajog.2010.01.080
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
OBJECTIVE: The objective of the study was to determine the value of maternal serum Down syndrome screening in patients affected by renal disease. STUDY DESIGN: A study group of 54 pregnant women with renal diseases defined before pregnancy, was compared with a control group of 108 patients matched for maternal age, maternal weight, smoking status, and gestational age. Maternal serum markers (free beta-human chorionic gonadotropin [hCG], total hCG, alpha-fetoprotein) expressed in multiple of median and maternal renal function markers (creatinine, beta 2-microglobulin, alpha 1-microglobulin) were assayed. RESULTS: The percentage of patients in the Down syndrome at-risk group (>1:250) using free beta-hCG was significantly higher (P < .02) in the renal disease group (48%) than in the control group (12%). No significant difference was observed for total hCG (25% vs 15%). CONCLUSION: Down syndrome screening using free beta-hCG is not applicable in patients with renal disease whatever the maternal serum creatinine and can be used with caution when total hCG is used.
引用
收藏
页码：60.e1 / 60.e4
页数：4
相关论文
共 50 条
  • [1] Down syndrome maternal serum screening: New policies
    Bernard, M.
    Muller, F.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2009, 24 (5-6): : 235 - 239
  • [2] Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening
    Wanapirak, Chanane
    Piyamongkol, Wirawit
    Sirichotiyakul, Supatra
    Tongprasert, Fuanglada
    Srisupundit, Kasemsri
    Luewan, Suchaya
    Traisrisilp, Kuntharee
    Jatavan, Phudit
    Tongsong, Theera
    BMC HEALTH SERVICES RESEARCH, 2019, 19 (01)
  • [3] Maternal serum screening for Down syndrome: are women's perceptions changing?
    Gidiri, M.
    McFarlane, J.
    Holding, S.
    Lindow, S. W.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 114 (04) : 458 - 461
  • [4] Asymptomatic hepatocellular carcinoma detected by maternal serum screening for Down syndrome
    Shyu, MK
    Cheng, WF
    Shih, JC
    Chen, FC
    Lee, CN
    Yang, PM
    Yu, SC
    Hsieh, FJ
    Lin, GJ
    JOURNAL OF MATERNAL-FETAL INVESTIGATION, 1997, 7 (02): : 102 - 104
  • [5] How important is consent in maternal serum screening for Down syndrome in France?: Information and consent evaluation in maternal serum screening for Down syndrome:: a French study
    Favre, Romain
    Duchange, Nathalie
    Vayssiere, Christophe
    Kohler, Monique
    Bouffard, Nicole
    Hunsinger, Marie-Chrsitine
    Kohler, Anne
    Mager, Cecile
    Neumann, Muriel
    Vayssiere, Christine
    Viville, Brigitte
    Herve, Christian
    Moute, Grgoire
    PRENATAL DIAGNOSIS, 2007, 27 (03) : 197 - 205
  • [6] Down syndrome maternal serum screening: Results' comments recommended by the accredited biologists
    Muller, F.
    Dreux, S.
    Czerkiewicz, I.
    Bernard, M.
    Guibourdenche, J.
    Lacroix, I.
    Moineau, M. -P.
    Read, M. -H.
    Sault, C.
    Thibaud, D.
    Veyrat, B.
    Bidat, L.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2014, 43 (09): : 671 - 679
  • [7] Down syndrome maternal serum marker screening after 18 weeks' gestation
    Muller, F
    Dreux, S
    Oury, JF
    Luton, D
    Uzan, S
    Uzan, M
    Levardon, M
    Dommergues, M
    PRENATAL DIAGNOSIS, 2002, 22 (11) : 1001 - 1004
  • [8] Prenatal diagnosis of trisomy 20 mosaicism by maternal serum screening for Down syndrome
    Chen, JH
    Hsu, TY
    Ou, CY
    Chang, LF
    Chang, SY
    Soong, YK
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1999, 86 (02): : 175 - 177
  • [9] Maternal serum screening in cases of mosaic and translocation Down Syndrome
    Dreux, Sophie
    Olivier, Camille
    Dupont, Jean-Michel
    Leporrier, Nathalie
    Oury, Jean-Francois
    Muller, Francoise
    PRENATAL DIAGNOSIS, 2008, 28 (08) : 699 - 703
  • [10] Experiences of mothers participating in maternal serum screening for Down's syndrome
    Salonen, R
    Kurki, L
    Lappalainen, M
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1996, 4 (02) : 113 - 119
12345